Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
The Lancet. Rheumatology|January 27, 2024
Efficacy, patient-reported outcomes, and safety of the anti-granulocyte macrophage colony-stimulating factor antibody otilimab (GSK3196165) in patients with rheumatoid arthritis: a randomised, phase 2b, dose-ranging studyChristopher D Buckley, Jesus A Simón-Campos, Vyacheslav Zhdan, et al.
Angiogenesis|May 11, 2024
Distinct roles of SOX9 in self-renewal of progenitors and mesenchymal transition of the endotheliumJilai Zhao, Laura Sormani, Sebastien Jacquelin, et al.
Nature Communications|May 8, 2021
Sox9 and Rbpj differentially regulate endothelial to mesenchymal transition and wound scarring in murine endovascular progenitorsJilai Zhao, Jatin Patel, Simranpreet Kaur, et al.
Elife|July 31, 2019
R-propranolol is a small molecule inhibitor of the SOX18 transcription factor in a rare vascular syndrome and hemangiomaJeroen Overman, Frank Fontaine, Jill Wylie-Sears, et al.
The Lancet. Rheumatology|January 26, 2024
Anti-granulocyte-macrophage colony-stimulating factor antibody otilimab in patients with hand osteoarthritis: a phase 2a randomised trialGeorg Schett, Chris Bainbridge, Mario Berkowitz, et al.
The Lancet. Rheumatology|January 27, 2024
MRI of the joint and evaluation of the granulocyte-macrophage colony-stimulating factor-CCL17 axis in patients with rheumatoid arthritis receiving otilimab: a phase 2a randomised mechanistic studyMark C Genovese, Mario Berkowitz, Philip G Conaghan, et al.
Plos One|March 14, 2019
Structural similarity, characterization of Poly Ethylene Glycol linkage and identification of product related variants in biosimilar pegfilgrastimRakesh Shekhawat, Chintan Kumar Shah, Akash Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 20, 2020
A Phase 3, Randomized, Open-label, Noninferiority Trial Evaluating Anti-Rabies Monoclonal Antibody Cocktail (TwinrabTM) Against Human Rabies Immunoglobulin (HRIG)Kevinkumar Kansagra, Deven Parmar, Sanjeev Kumar Mendiratta, et al.
The Journal of Allergy and Clinical Immunology|September 1, 2012
Novel targeted therapies for eosinophilic disordersMichael E Wechsler, Patricia C Fulkerson, Bruce S Bochner, et al.
The European Respiratory Journal|October 13, 2022
A randomised trial of anti-GM-CSF otilimab in severe COVID-19 pneumonia (OSCAR)Jatin Patel, Damon Bass, Albertus Beishuizen, et al.
Pageof 8